Cargando…
Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule
Nicotinamide adenine dinucleotide (NAD+) is an established cofactor for enzymes serving cellular metabolic reactions. More recent research identified NAD+ as a signaling molecule and substrate for sirtuins and poly-adenosine 5′-diphosphate polymerases; enzymes that regulate protein deacetylation and...
Autores principales: | Elhassan, Yasir S., Philp, Andrew A., Lavery, Gareth G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686634/ https://www.ncbi.nlm.nih.gov/pubmed/29264533 http://dx.doi.org/10.1210/js.2017-00092 |
Ejemplares similares
-
ODP443 Targeting NAD+ availability modulates 11β- Hydroxysteroid dehydrogenase 1 activity in mouse and human cell lines and primary cells
por: Kabli, Ali, et al.
Publicado: (2022) -
The emergence of the nicotinamide riboside kinases in the regulation of NAD(+) metabolism
por: Fletcher, Rachel S, et al.
Publicado: (2018) -
Targeted, LCMS-based Metabolomics for Quantitative Measurement of NAD(+) Metabolites
por: Trammell, Samuel AJ, et al.
Publicado: (2013) -
Circadian cardiac NAD(+) metabolism, from transcriptional regulation to healthy aging
por: Carpenter, Bryce J., et al.
Publicado: (2022) -
New tricks of an old molecule: lifespan regulation by p53
por: Bauer, Johannes H, et al.
Publicado: (2006)